Manganeso dioxidozko superkondentsadore hibridoen karakterizazio elektrokimikoa

[EUS] Manganeso dioxidozko superkondentsadore hibridoen karakterizazio elektrokimikoa, material aktiboen sintesi eta karakterizazio fisiko-kimikoa eta banakako elektrodoen ikerketa

Nanostructured Manganese Dioxide for Hybrid Supercapacitor Electrodes

Hybrid supercapacitors, as emerging energy storage devices, have gained much attention in recent years due to their high energy density, fast charge/discharge and long cyclabilities. Among the wide range of systems covered by this topic, low cost, environmental friendliness and high power provide MnO2 with great characteristics to be a competitive candidate. The present work reports a hybrid aqueous supercapacitor system using a commercial activated carbon as the negative electrode and a synthesized manganese dioxide as the positive electrode. Two manganese dioxide polymorphs (α-MnO2 and δ-MnO2) were tested in different neutral and basic aqueous electrolytes. In this way, full cell systems that reached an energy density of 15.6 Wh kg−1 at a power density of 1 kW kg−1 were achieved. The electrode–electrolyte combination explored in this study exhibits excellent performance without losing capacity after 5000 charge/discharge cycles, leading to a promising approach towards more sustainable, high-performance energy storage systems.This research was funded by the Ministerio de Ciencia, Innovación y Universidades (PID2019-107468RB-C21 and TED2021-131517B-C21) and Gobierno Vasco/Eusko Jaurlaritza (IT1546-22)

Jumping-based asymmetries are negatively associated with jump, change of direction, and repeated sprint performance, but not linear speed, in adolescent handball athletes

The aim of the present study was to determine the association of multi-directional jumping asymmetries with measures of physical performance. Forty-two youth handball athletes (age: 16.0 ± 1.3 years; body height: 174.11 ± 7.3 cm; body mass: 70.49 ± 13.3 kg) performed a mid-season fitness test battery consisting of single leg countermovement, lateral and broad jump tests, two change of direction speed (CODS) tests, an 8 x 10 m repeated sprint test, and a 20 m sprint. The Kappa coefficient showed only ‘slight’ levels of agreement (K range = -0.05 to 0.15), indicating that asymmetries rarely favoured the same side during each of the jump tests. The single leg countermovement jump showed significantly (p = 0.006) larger asymmetries (11.2 ± 8.4) than the broad jump (6.4 ± 4.6) and significant correlations were present between jumping asymmetries and jump (r = -0.32 to -0.52), CODS (r = 0.31 to 0.32) and repeated sprint (r = 0.35 to 0.40) performance. The findings of the present study highlight the independent nature of jumping asymmetries and associations with measures of physical performance. Practitioners are encouraged to use multiple tests to detect existing side differences and consider appropriate training interventions for the reduction of inter-limb asymmetries

Stripping of PFA Fluoropolymer Coatings Using a Nd:YAG Laser (Q-Switch) and an Yb Fiber Laser (CW)

Fluoropolymers such as PFA are used as coatings for the protection of metal substrates due to their high chemical inertia and non-stick properties. These are “wear and tear” coatings and they degrade, at which point they should be removed for a new application. The removal of these types of coating by laser is of interest due to the process’s flexibility, precision, ease of automation, and environmental sustainability. The efficiency of the procedure was shown with the use of a source in a pulsed Nd:YAG and a source in continuous mode of fiber (Yb). The rates of stripping (cm2/min) and fluence (J/cm2) were analyzed and related to the power of the laser sources. Variations of the substrate after stripping were studied: roughness and hardness. The properties of the coating, thickness, roughness, water sliding angle, and microhardness were also evaluated. It was concluded that the laser in continuous mode was more efficient than the pulsed laser; laser removal of fluoropolymers has a strong relationship with reflectivity, and the mechanical and surface properties of the substrate after stripping remained virtually unchanged

Un altre urbanisme és possible. La nova praxi urbana davant del canvi d'època

Aquest article passa revista a una munió d’iniciatives que estan sorgint en el camp de la urbanística i de l’arquitectura davant la percepció general de canvi d’època. Aquesta iniciatives parteixen del fet que l’urbanisme és política, i es basen en quatre principis: estratègia del “re” (reciclar, regenerar, rehabilitar, etc.), mediació i participació social, transdisciplinarietat i Beta permanent (disseny col·laboratiu).Este artículo pasa revista a una multitud de iniciativas que están surgiendo en el campo de la urbanística y la arquitectura ante la percepción general de cambio de época. Esta iniciativas parten de que el urbanismo es política, y se basan en cuatro principios: estrategia del "re" (reciclar, regenerar, rehabilitar, etc.), mediación y participación social, transdisciplinariedad y Beta permanente (diseño colaborativo)

Marco activo de recursos de innovación docente: Madrid

Una guía de espacios e instituciones para actividades educativas complementarias en enseñanza secundaria y Formación Profesional

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection